PRAX
Praxis Precision Medicines, Inc.
$332.99
+9.04 (+2.79%)
At close · Jul 8
Market Cap
$9.28B
Shares
27,878,774
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$332.99
Open$323.47
Day$317.04–336.72
52W$37.19–366.52
Avg vol 30d626K
Short int3.6M · 12.8% float · 5.5d
Short vol75%
Last earningsMay 13, 2026
DataOct 2020–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+27%
above
Price vs 50-day avg
+6%
above
RSI (14)
58
neutral
MACD trend
Positive
52-week position
90%
near high
Momentum
relative strength
1-month return
+31%
trailing
6-month return
+19%
trailing
YTD return
+13%
this year
Relative strength
+11%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $313 › 200d $262 — 50d above 200d
Institutional flow
Distributing
4 of 299 funds reported for Jun 30 · net -24.8K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
12.80% of float · ▼ -2.3% MoM · 5.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
299 holders — near 2-yr high, broad support
Squeeze score
58
elevated · 0–100
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
−32%
Y/Y
Free cash flow
$-249.1M
Balance sheet
$357.3M
net cash
Quant / Vol
risk profile
Volatility
199%
annualized · 1-yr
Max drawdown
−36%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 31, 2026
Est · unconfirmed
· in 8 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+27%
Bullish
Price vs 50-day avg
+6%
Bullish
RSI (14)
58
Neutral
MACD trend
Positive
Bullish
52-week position
90%
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $313 › 200d $262 — 50d above 200d
Institutional flow
Distributing
4 of 299 funds reported for Jun 30 · net -24.8K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
12.80% of float · ▼ -2.3% MoM · 5.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
299 holders — near 2-yr high, broad support
Price context
position in its 52-week range
52-wk low $37
Now $333 · 90%
52-wk high $367
vs 200-day avg +27%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PRAX
this stock
Praxis Precision Medicines, Inc.
|
$9.28B | +13.0% | +0.0% | — | 12.8% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PRAX | -0.5% | +31.5% | +18.6% | -0.5% | +13.0% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -0.4% | +30.7% | +11.1% | -0.4% | +3.7% |